The Porter Law Group recently secured a $2.3 million settlement in a prostate cancer misdiagnosis medical malpractice case involving the failure to screen for and diagnose prostate cancer, leading to devastating consequences for a 66-year-old patient. The case highlighted serious concerns about patient care standards and the critical importance of prostate cancer screening discussions between physicians and their patients.
Schedule your free consultation today and see how we can help.
The case centered around a primary care physician’s failure to discuss or offer PSA (Prostate-Specific Antigen) testing to his patient over the course of more than 25 years of care. Despite the client’s family history of prostate cancer, which significantly increased his risk for developing the disease, the physician never engaged in any discussions about this crucial screening tool. This oversight ultimately led to a delayed diagnosis of Stage IV prostate cancer with extensive metastasis in June 2023.
During the investigation, it became clear that the physician had made several concerning decisions regarding patient care. The doctor admitted in deposition testimony that he deliberately chose not to discuss PSA testing with his patients, citing questionable justifications including his belief that local patients were unable to make “perfectly objective” decisions about their healthcare. This position stood in stark contrast to established medical guidelines and recommendations from numerous professional organizations.
The investigation revealed that the physician had failed to follow multiple professional guidelines, including those from the U.S. Preventive Services Task Force (USPSTF), the American Cancer Society, and the Medical Society of the State of New York. These organizations consistently recommend shared decision-making between doctors and patients regarding PSA testing. The physician’s decision to withhold this information effectively denied the client the opportunity to make informed decisions about his own healthcare.
The client’s medical history demonstrated a pattern of proactive health maintenance, including regular check-ups, compliance with other cancer screenings, and positive lifestyle changes such as smoking cessation. This history directly contradicted the physician’s characterization of the client as someone unable to make informed medical decisions.
Medical experts in urology and oncology who reviewed the case concluded that had the client received regular PSA screening, his cancer likely would have been diagnosed at a much earlier stage, when the five-year survival rate exceeds 99%. Instead, the cancer was discovered only after it had spread extensively throughout his body, resulting in a significantly reduced life expectancy and requiring aggressive palliative treatments in this prostate cancer misdiagnosis case.
The impact on the client’s life has been devastating. Since his diagnosis, he has endured multiple rounds of radiation therapy, chemotherapy, and hormone treatments, resulting in severe side effects including significant weight loss and complications requiring hospitalization. Beyond the physical toll, the client faces the emotional burden of knowing that his terminal diagnosis might have been prevented with proper screening and early detection.
The $2.3 million settlement represents the physician’s full primary insurance coverage limit. This amount, while significant, acknowledges the profound impact of the delayed diagnosis on the client’s life and future, as well as the clear departure from accepted medical standards of care in this prostate cancer misdiagnosis case.
This case serves as a crucial reminder of the importance of proper cancer screening protocols and the essential role of informed patient participation in healthcare decisions. For anyone who has concerns about their medical care or believes they may have experienced similar negligence, it’s crucial to seek legal consultation promptly. The Porter Law Group continues to advocate for patients’ rights and proper medical care standards, ensuring that healthcare providers are held accountable for their professional obligations to patients.
